The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

May. 25, 2018
Applicants:

Yale University, New Haven, CT (US);

Susan Marie Metcalfe, Cambridge, GB;

Inventors:

Susan Marie Metcalfe, Cambridge, GB;

Tarek Fahmy, New Haven, CT (US);

Assignee:

Yale University, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/42 (2017.01); B82Y 5/00 (2011.01); A61K 38/18 (2006.01); C07K 16/28 (2006.01); A61K 47/69 (2017.01); A61K 9/48 (2006.01); A61K 38/20 (2006.01);
U.S. Cl.
CPC ...
A61K 47/42 (2013.01); A61K 9/4866 (2013.01); A61K 38/185 (2013.01); A61K 38/1808 (2013.01); A61K 38/204 (2013.01); A61K 38/2093 (2013.01); A61K 47/6907 (2017.08); B82Y 5/00 (2013.01); C07K 16/2863 (2013.01);
Abstract

There are provided compositions and methods for treatment of neurodegeneative diseases and CNS injury. The compositions a pharmaceutically acceptable carrier solution; and a plurality of biodegradable nanoparticles, wherein the nanoparticles comprise a targeting moiety that is able to bind selectively to the surface of a neural stem cell and wherein the nanoparticles further comprise factors such as leukaemia inhibitory factor (LIF); XAV939 and/or one or more of: brain-derived neurotrophic factor (BDNF) or an agonist thereof; epidermal growth factor (EGF) or an agonist thereof; glial cell-derived neurotrophic factor (GDNF) or an agonist thereof; retinoic acid and derivatives thereof; ciliary neurotrophic factor (CTNF) or an agonist thereof; and Wnt5A. The biodegradable nanoparticles may deliver via controlled time release.


Find Patent Forward Citations

Loading…